Rezultati pretrage - Jann, Henning
- Prikaz rezultata 1 – 19 od 19
-
1
-
2
A case report of an excellent response to interferon- α in a patient with functional metastasized neuroendocrine tumor refractory to other treatments od Özdirik, Burcin, Tacke, Frank, Benz, Fabian, Amthauer, Holger, Fehrenbach, Uli, Roderburg, Christoph, Jann, Henning
Izdano 2020Tekst -
3
-
4
Prognostic Value of the Largest Lesion Size for Progression-Free Survival in Patients with NET Undergoing Salvage PRRT with [(177)Lu]Lu-DOTATOC od Galler, Markus, Rogasch, Julian M. M., Huang, Kai, Jann, Henning, Plehm, Kristina, Wetz, Christoph, Amthauer, Holger
Izdano 2022Tekst -
5
Influence of Gender on Therapy and Outcome of Neuroendocrine Tumors of Gastroenteropancreatic Origin: A Single-Center Analysis od Mogl, Martina T., Dobrindt, Eva M., Buschermöhle, Josephine, Bures, Claudia, Pratschke, Johann, Amthauer, Holger, Wetz, Christoph, Jann, Henning
Izdano 2020Tekst -
6
Asphericity of Somatostatin Receptor Expression in Neuroendocrine Tumors: An Innovative Predictor of Outcome in Everolimus Treatment? od Wetz, Christoph, Rogasch, Julian, Genseke, Philipp, Schatka, Imke, Furth, Christian, Kreissl, Michael, Jann, Henning, Venerito, Marino, Amthauer, Holger
Izdano 2020Tekst -
7
The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [(177)Lu]Lu-DOTATOC-PRRT: A Retrospective Analysis od Ruhwedel, Tristan, Rogasch, Julian M. M., Huang, Kai, Jann, Henning, Schatka, Imke, Furth, Christian, Amthauer, Holger, Wetz, Christoph
Izdano 2021Tekst -
8
Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3) od Apostolidis, Leonidas, Dal Buono, Arianna, Merola, Elettra, Jann, Henning, Jäger, Dirk, Wiedenmann, Bertram, Winkler, Eva Caroline, Pavel, Marianne
Izdano 2021Tekst -
9
Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future od Stueven, Anna Kathrin, Kayser, Antonin, Wetz, Christoph, Amthauer, Holger, Wree, Alexander, Tacke, Frank, Wiedenmann, Bertram, Roderburg, Christoph, Jann, Henning
Izdano 2019Tekst -
10
Primary Neuroendocrine Neoplasms of the Breast: Case Series and Literature Review od Özdirik, Burcin, Kayser, Antonin, Ullrich, Andrea, Savic, Lynn J., Reiss, Markus, Tacke, Frank, Wiedenmann, Bertram, Jann, Henning, Roderburg, Christoph
Izdano 2020Tekst -
11
A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report od Özdirik, Burcin, Amthauer, Holger, Schatka, Imke, Goretzki, Peter E., Mogl, Martina T., Fehrenbach, Uli, Tacke, Frank, Jann, Henning, Roderburg, Christoph
Izdano 2021Tekst -
12
Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors od Hellberg, Teresa, Mohr, Raphael, Geisler, Lukas, Knorr, Jana, Wree, Alexander, Demir, Münevver, Benz, Fabian, Lambrecht, Joeri, Loosen, Sven H., Tacke, Frank, Roderburg, Christoph, Jann, Henning, Özdirik, Burcin
Izdano 2020Tekst -
13
Automatized Hepatic Tumor Volume Analysis of Neuroendocrine Liver Metastases by Gd-EOB MRI—A Deep-Learning Model to Support Multidisciplinary Cancer Conference Decision-Making od Fehrenbach, Uli, Xin, Siyi, Hartenstein, Alexander, Auer, Timo Alexander, Dräger, Franziska, Froböse, Konrad, Jann, Henning, Mogl, Martina, Amthauer, Holger, Geisel, Dominik, Denecke, Timm, Wiedenmann, Bertram, Penzkofer, Tobias
Izdano 2021Tekst -
14
The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors od Geisler, Lukas, Mohr, Raphael, Lambrecht, Joeri, Knorr, Jana, Jann, Henning, Loosen, Sven H., Özdirik, Burcin, Luedde, Tom, Hammerich, Linda, Tacke, Frank, Wree, Alexander, Hellberg, Teresa, Roderburg, Christoph
Izdano 2021Tekst -
15
Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter... od Krug, Sebastian, Kegel, Thomas, Gress, Thomas M., Rinke, Anja, Apostolidis, Leonidas, Jann, Henning, König, Alexander, Hörsch, Dieter, Schrader, Jörg, Ettrich, Thomas J., Richter, Michael, Steighardt, Jörg, Michl, Patrick
Izdano 2021Tekst -
16
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies od Özdirik, Burcin, Stueven, Anna, Knorr, Jana, Geisler, Lukas, Mohr, Raphael, Demir, Münevver, Hellberg, Teresa, Loosen, Sven H., Benz, Fabian, Wiedenmann, Bertram, Tacke, Frank, Wree, Alexander, Jann, Henning, Roderburg, Christoph
Izdano 2020Tekst -
17
Treatment Approaches and Outcome of Patients with Neuroendocrine Neoplasia Grade 3 in German Real-World Clinical Practice od Luecke, Simone, Fottner, Christian, Lahner, Harald, Jann, Henning, Zolnowski, Dominik, Quietzsch, Detlef, Grabowski, Patricia, Cremer, Birgit, Maasberg, Sebastian, Pape, Ulrich-Frank, Mueller, Hans-Helge, Gress, Thomas Matthias, Rinke, Anja
Izdano 2022Tekst -
18
Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms od Detjen, Katharina M., Otto, Raik, Giesecke, Yvonne, Geisler, Lukas, Riemer, Pamela, Jann, Henning, Grötzinger, Carsten, Sers, Christine, Pascher, Andreas, Lüdde, Tom, Leser, Ulf, Wiedenmann, Bertram, Sigal, Michael, Tacke, Frank, Roderburg, Christoph, Hammerich, Linda
Izdano 2021Tekst -
19
Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors—Results from an Exploratory Study od Özdirik, Burcin, Stueven, Anna K., Mohr, Raphael, Geisler, Lukas, Wree, Alexander, Knorr, Jana, Demir, Münevver, Vucur, Mihael, Loosen, Sven H., Benz, Fabian, Reiss, Markus, Wiedenmann, Bertram, Tacke, Frank, Jann, Henning, Hellberg, Teresa, Roderburg, Christoph
Izdano 2020Tekst